> Details
Figueroa, Xavier F;
Poblete, M Inés;
Boric, Mauricio P;
Mendizábal, Victoria E;
Adler‐Graschinsky, Edda;
Huidobro‐Toro, J Pablo
Clonidine‐induced nitric oxide‐dependent vasorelaxation mediated by endothelial α2‐adrenoceptor activation
Sharing
Reference
management
Direct link
Bookmarks
Remove from
bookmarks
Share this by email
Share this on Twitter
Share this on Facebook
Share this on Whatsapp
- Media type: E-Article
- Title: Clonidine‐induced nitric oxide‐dependent vasorelaxation mediated by endothelial α2‐adrenoceptor activation
- Contributor: Figueroa, Xavier F; Poblete, M Inés; Boric, Mauricio P; Mendizábal, Victoria E; Adler‐Graschinsky, Edda; Huidobro‐Toro, J Pablo
- Published: Wiley, 2001
- Published in: British Journal of Pharmacology
- Extent: 957-968
- Language: English
- DOI: 10.1038/sj.bjp.0704320
- ISSN: 0007-1188; 1476-5381
- Keywords: Pharmacology
- Abstract: <jats:p> <jats:list list-type="explicit-label"> <jats:list-item><jats:p>To assess the involvement of endothelial α<jats:sub>2</jats:sub>‐adrenoceptors in the clonidine‐induced vasodilatation, the mesenteric artery of Sprague Dawley rats was cannulated and perfused with Tyrode solution (2 ml min<jats:sup>−1</jats:sup>). We measured perfusion pressure, nitric oxide (NO) in the perfusate using chemiluminescence, and tissue cyclic GMP by RIA.</jats:p></jats:list-item> <jats:list-item><jats:p>In phenylephrine‐precontracted mesenteries, clonidine elicited concentration‐dependent vasodilatations associated to a rise in luminal NO. One hundred n<jats:sc>M</jats:sc> rauwolscine or 100 μ<jats:sc>M</jats:sc> L<jats:sup>ω</jats:sup>‐nitro‐<jats:sc>L</jats:sc>‐arginine antagonized the clonidine‐induced vasodilatation. Guanabenz, guanfacine, and oxymetazoline mimicked the clonidine‐induced vasorelaxation.</jats:p></jats:list-item> <jats:list-item><jats:p>In non‐contracted mesenteries, 100 n<jats:sc>M</jats:sc> clonidine elicited a maximal rise of NO (123±13 pmol); associated to a peak in tissue cyclic GMP. Endothelium removal, L<jats:sup>ω</jats:sup>‐nitro‐<jats:sc>L</jats:sc>‐arginine, or rauwolscine ablated the rise in NO. One hundred n<jats:sc>M</jats:sc> aminoclonidine, guanfacine, guanabenz, UK14,304 and oxymetazoline mimicked the clonidine‐induced surge of NO. Ten μ<jats:sc>M</jats:sc> ODQ obliterated the clonidine‐induced vasorelaxation and the associated tissue cyclic GMP accumulation; 10 – 100 n<jats:sc>M</jats:sc> sildenafil increased tissue cyclic GMP accumulation without altering the clonidine‐induced NO release.</jats:p></jats:list-item> <jats:list-item><jats:p>α<jats:sub>2</jats:sub>‐Adrenergic blockers antagonized the clonidine‐induced rise in NO. Consistent with a preferential α<jats:sub>2D</jats:sub>‐adrenoceptor activation, the K<jats:sub>B</jats:sub>s for yohimbine, rauwolscine, phentolamine, WB‐4101, and prazosin were: 6.8, 24, 19, 165, and 1489 n<jats:sc>M</jats:sc>, respectively.</jats:p></jats:list-item> <jats:list-item><jats:p>Rat pretreatment with 100 mg kg<jats:sup>−1</jats:sup> 6‐hydroxydopamine reduced 95% tissue noradrenaline and 60% neuropeptide Y. In these preparations, 100 n<jats:sc>M</jats:sc> clonidine elicited a rise of 91.9±15.5 pmol NO. Perfusion with 1 μ<jats:sc>M</jats:sc> guanethidine or 1 μ<jats:sc>M</jats:sc> guanethidine plus 1 μ<jats:sc>M</jats:sc> atropine did not modify the NO surge evoked by 100 n<jats:sc>M</jats:sc> clonidine.</jats:p></jats:list-item> <jats:list-item><jats:p>Clonidine and congeners activate endothelial α<jats:sub>2D</jats:sub>‐adrenoceptors coupled to the <jats:sc>L</jats:sc>‐arginine pathway, suggesting that the antihypertensive action of clonidine involves an endothelial vasorelaxation mediated by NO release, in addition to presynaptic mechanisms.</jats:p></jats:list-item> </jats:list> </jats:p><jats:p><jats:italic>British Journal of Pharmacology</jats:italic> (2001) <jats:bold>134</jats:bold>, 957–968; doi:<jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1038/sj.bjp.0704320">10.1038/sj.bjp.0704320</jats:ext-link></jats:p>
-
Description:
<jats:p>
<jats:list list-type="explicit-label">
<jats:list-item><jats:p>To assess the involvement of endothelial α<jats:sub>2</jats:sub>‐adrenoceptors in the clonidine‐induced vasodilatation, the mesenteric artery of Sprague Dawley rats was cannulated and perfused with Tyrode solution (2 ml min<jats:sup>−1</jats:sup>). We measured perfusion pressure, nitric oxide (NO) in the perfusate using chemiluminescence, and tissue cyclic GMP by RIA.</jats:p></jats:list-item>
<jats:list-item><jats:p>In phenylephrine‐precontracted mesenteries, clonidine elicited concentration‐dependent vasodilatations associated to a rise in luminal NO. One hundred n<jats:sc>M</jats:sc> rauwolscine or 100 μ<jats:sc>M</jats:sc> L<jats:sup>ω</jats:sup>‐nitro‐<jats:sc>L</jats:sc>‐arginine antagonized the clonidine‐induced vasodilatation. Guanabenz, guanfacine, and oxymetazoline mimicked the clonidine‐induced vasorelaxation.</jats:p></jats:list-item>
<jats:list-item><jats:p>In non‐contracted mesenteries, 100 n<jats:sc>M</jats:sc> clonidine elicited a maximal rise of NO (123±13 pmol); associated to a peak in tissue cyclic GMP. Endothelium removal, L<jats:sup>ω</jats:sup>‐nitro‐<jats:sc>L</jats:sc>‐arginine, or rauwolscine ablated the rise in NO. One hundred n<jats:sc>M</jats:sc> aminoclonidine, guanfacine, guanabenz, UK14,304 and oxymetazoline mimicked the clonidine‐induced surge of NO. Ten μ<jats:sc>M</jats:sc> ODQ obliterated the clonidine‐induced vasorelaxation and the associated tissue cyclic GMP accumulation; 10 – 100 n<jats:sc>M</jats:sc> sildenafil increased tissue cyclic GMP accumulation without altering the clonidine‐induced NO release.</jats:p></jats:list-item>
<jats:list-item><jats:p>α<jats:sub>2</jats:sub>‐Adrenergic blockers antagonized the clonidine‐induced rise in NO. Consistent with a preferential α<jats:sub>2D</jats:sub>‐adrenoceptor activation, the K<jats:sub>B</jats:sub>s for yohimbine, rauwolscine, phentolamine, WB‐4101, and prazosin were: 6.8, 24, 19, 165, and 1489 n<jats:sc>M</jats:sc>, respectively.</jats:p></jats:list-item>
<jats:list-item><jats:p>Rat pretreatment with 100 mg kg<jats:sup>−1</jats:sup> 6‐hydroxydopamine reduced 95% tissue noradrenaline and 60% neuropeptide Y. In these preparations, 100 n<jats:sc>M</jats:sc> clonidine elicited a rise of 91.9±15.5 pmol NO. Perfusion with 1 μ<jats:sc>M</jats:sc> guanethidine or 1 μ<jats:sc>M</jats:sc> guanethidine plus 1 μ<jats:sc>M</jats:sc> atropine did not modify the NO surge evoked by 100 n<jats:sc>M</jats:sc> clonidine.</jats:p></jats:list-item>
<jats:list-item><jats:p>Clonidine and congeners activate endothelial α<jats:sub>2D</jats:sub>‐adrenoceptors coupled to the <jats:sc>L</jats:sc>‐arginine pathway, suggesting that the antihypertensive action of clonidine involves an endothelial vasorelaxation mediated by NO release, in addition to presynaptic mechanisms.</jats:p></jats:list-item>
</jats:list>
</jats:p><jats:p><jats:italic>British Journal of Pharmacology</jats:italic> (2001) <jats:bold>134</jats:bold>, 957–968; doi:<jats:ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" xlink:href="10.1038/sj.bjp.0704320">10.1038/sj.bjp.0704320</jats:ext-link></jats:p> - Footnote:
- Access State: Open Access